Resveratrol addition to CHO cell culture media: The effect on cell growth, monoclonal antibody synthesis and its chemical modification by Toronjo‐Urquiza, L. et al.
This is a repository copy of Resveratrol addition to CHO cell culture media: The effect on 
cell growth, monoclonal antibody synthesis and its chemical modification.




Toronjo Urquiza, L., Acosta Martin, A.E., James, D.C. et al. (2 more authors) (2019) ‐ ‐
Resveratrol addition to CHO cell culture media: The effect on cell growth, monoclonal 
antibody synthesis and its chemical modification. Biotechnology Progress. ISSN 
8756-7938 
https://doi.org/10.1002/btpr.2940
This is the peer reviewed version of the following article: Toronjo Urquiza, L. , ‐
Acosta Martin, A. E., James, D. C., Nagy, T. and Falconer, R. J. (2019), Resveratrol ‐
addition to CHO cell culture media: The effect on cell growth, monoclonal antibody 
synthesis and its chemical modification. Biotechnol Progress, which has been published in 
final form at https://doi.org/10.1002/btpr.2940. This article may be used for non-commercial





Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless 
indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by 
national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of 
the full text version. This is indicated by the licence information on the White Rose Research Online record 
for the item. 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
Resveratrol addition to CHO cell culture media: The effect on cell growth, 
monoclonal antibody synthesis and its chemical modification. 
 
Luis Toronjo-Urquiza1, Adelina E. Acosta-Martin2, David C. James1, Tibor Nagy3, Robert J. Falconer4* 
1 Department of Chemical & Biological Engineering, ChELSI Institute, University of Sheffield, 
Sheffield, S1 3JD, England 
2 biOMICS Facility, Faculty of Science Mass Spectrometry Centre, University of Sheffield, Sheffield, S3 
7HF, England 
3 Fujifilm Diosynth Biotechnologies, Belasis Ave, Stockton-on-Tees, Billingham TS23 1LH, England. 
4 Department of Chemical Engineering and Advanced Materials, University of Adelaide, SA 5005, 
Australia. 
* Corresponding author. Email robert.falconer@adelaide.edu.au 
 
Abstract 
The effect of the addition of resveratrol to cell culture media during the production of monoclonal 
antibodies was investigated. Treatments of Chinese hamster ovary (CHO) cells expressing 
immunoglobulin G (IgG) with 25 and 50 µM resveratrol showed that resveratrol was capable of slowing 
cell growth whilst almost doubling cell specific productivity to 4.7 ± 0.6 pg IgG/cell⋅day, resulting in up 
to a 1.37-fold increase of the final IgG titre. A resveratrol concentration of 50 µM slowed the 
progression through the cell cycle temporarily by trapping cells in the S-phase. Cation exchange 
chromatography showed no significant difference in the composition of acidic or basic IgG species and 
size exclusion chromatography indicated no change in fragmentation or aggregation of the 
recombinant IgG in the treatment groups. Resveratrol could be used as a chemical additive to CHO 
media where it would enhance IgG productivity and provide a degree of protection against hydroxyl 
and superoxide free radicals, expanding the range of options for process improvement available to 
monoclonal antibody manufacturers. 
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The main challenge for the biopharmaceutical industry is to produce therapeutic proteins with 
consistent quality, with good yields and at relatively low cost. One approach was to focus on the 
development of more reliable production cell lines.1 Another strategy used chemical additives to cell 
culture media to improve the therapeutic protein yeilds. These additives, sometimes referred to as 
chemical chaperones are not nutrients but improve product yields by either modulating cell growth, 
stabilising the product or reducing chemical modification. Sodium butyrate, 2, 3 zinc 4 and valeric acid 
5, 6 are examples of chemicals that led to an improvement of the recombinant protein production. 
Identification of further additives is desirable in order to increase the number of options cell culture 
process development. The introduction of a new media component to a cell culture reactor has a 
series of risks that need to be mitigated before it can go into commercial use. In the case of addition 
of a chemical like resveratrol to cell culture media, the following potential effects of the chemical need 
to be assessed, (A) its cell toxicity, (B) its impact on protein synthesis and post translational 
modification, (C) any reaction with the therapeutic protein, and (D) its potential to catalyse chemical 
modification of the therapeutic protein. 
Resveratrol (3, 5, 4-trihydroxystilbene) is a stilbene found in a variety of fruits and vegetables. It is a 
widely studied antioxidant, partially due to its presence in red wine and its reputed health benefits. 
Its structure consists of two phenolic groups joined by an ethene, enabling electron delocalisation 
across the molecule (Figure 1). Resveratrol can be radicalised at all three hydroxyl groups with 4 being 
the most stable 7 and spread the energised electron over the entire molecule providing radical 
stabilisation. Resveratrols ability to scavenge free radicals, including superoxide and hydroxyl radicals, 
protects against peroxidation of membrane lipids and DNA.8 Resveratrol is also believed to be an 
activator of SIRT1, which enhances mitochondrial oxidative phosphorylation in mice.9,10  
Research on resveratrols effect on CHO cells is limited, but indicates that resveratrol could have a 
protective effect. Resveratrol can provide protection from H2O2 induced DNA damage if added 3 hours 
prior to the addition of H2O2.11,12 It was also shown that it can restore redox balance from induced 
oxidative stress, by inhibiting the mitochondrial proteasome.13 Resveratrol seems to regulate CHO 
cells by upregulating 5ADP-activated protein kinase (AMPK) and its metabolic target acetyl-CoA 
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carboxylase for concentrations up to 50 µM.14 Resveratrol can be used as a protective agent when 
CHO cells are under stress conditions induced by beauvericin, a strong cytotoxic oxidative agent.15   
Resveratrol is a bioactive chemical that seems to have complex effects on cells. Only one study in the 
past has investigated the use of this molecule in biopharmaceutical production. Resveratrol was not 
able to improve recombinant production by inhibiting autophagy at the single concentration tested.16 
A recent screening study identified the potential of resveratrol (and series of other antioxidants) as 
possible media additives as they were found to slow CHO cell growth and increase cell specific IgG 
production at small-scale.17  
The aim of the current study is to further examine the effect of resveratrol on the CHO cell culture 
over a longer time period and study its effect on quality of IgG synthesised in its presence. This was 
done in order to determine whether this chemical is suitable as an additive in cell culture media during 
the production of recombinant protein products where its antioxidant protperties may be beneficial.  
 
Materials and Methods  
Cell Line and Reagents  
The reagents: dimethyl sulfoxide (DMSO), phosphate buffered saline (PBS), phenyl vinyl sulfone, 
RNAse I, propidium iodide, Tris(2-carboxyethyl) phosphine hydrochloride (TCEP), laemmli buffer, 
glycine, iodoacetic acid (IAA); were supplied by Sigma-Aldrich (St. Louis, Missouri, USA). OptiCHOTM 
free serum media, L-glutamine were supplied by Thermo Fisher Scientific (Ulm, Germany). Hygromicin 
B was supplied by Invitrogen (Carlsbad, California, USA). Tris was supplied by SLS (Nottingham, UK).  
The cell line used was a stable recombinant DG44 CHO cell line that expressed an IgG monoclonal 
antibody, provided by Fujifilm Diosynth Biotechnologies (Billingham, UK). The cell line was grown in 
suspension in an OptiCHOTM free serum media supplemented with 8mM L-glutamine and 100 mg/L 
hygromicin B. An initial culture was maintained in a shaking incubator with 5% CO2 modified 
atmosphere at 37oC. Cells were then seeded into new media at 0.2x106 viable cells/ml every 3-4 days. 
 
Cell Cycle Analysis 
Treatments were carried out in 1 ml cultures in a 24-well plate platform with an initial viable cell 
density (VCD) of 0.2x106 cells/ml. Wells were then treated at time 0 with different concentrations of 
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ヴWゲ┗Wヴ;デヴﾗﾉ Sｷﾉ┌デWS ｷﾐ ヵ´ﾉ ﾗa DMSO デﾗ ; aｷﾐ;ﾉ concentrations of 0, 10, 25, 50, 75 and 100 µM. Cells were 
grown for a period of 3 days under static conditions. VCD was measured using a Beckman-Coulter Vi-
cellTM XR cell viability analyser (Indianapolis, Indiana, USA). In parallel, samples were centrifuged for 
10 minutes at 400 g, the supernatant collected, and the IgG concentration measured using bio-layer 
interferometry with a Pall FortéBio Octet® QKe (Fremont, California, USA). Cultures were collected at 
0, 8, 16, 24, 32, 40, 48 and 72 hours. A modified propidium iodide staining protocol was used to 
measure cell cycle distribution.18 Finally, samples were measured with an Attune NxT Flow Cytometer 
& autosampler (Thermo Fisher Scientific) and analysed with FlowJoTM v10 (San Carlos, California, USA). 
 
33 ml Erlenmeyer flask CHO Cell Growth and IgG Expression 
Flasks with an initial concentration of 0.2x106 cells/ml in 33ml culture volume were grown for 10 days 
under a batch feeding regime with the same conditions specified in the cell culture section.  
Flasks were treated at days 0, 3 and 6 with 0, 10, 25 and 50 µM final concentrations of resveratrol. A 
read-out of the viable cell density, viability and the IgG concentration was performed every 24 hours. 
This experiment was done in two independent triplicates. 
VCD, viability and IgG concentration was measured as specified before. Specific protein production 
(qp) was determined by dividing the total protein produced after ten days incubation by the integral 
of the VCD curve over the same duration.19 ݍ௣(݃݌ ݈݈ܿ݁ · Τݕܽ݀ ) = Ɋ݃)݊݋݅ݐܽݎݐ݊݁ܿ݊݋ܥ ݐܾ݊ܽ݊݅݉݋ܴܿ݁ ݈ܽ݊݅ܨ ׬Τ(ܮ݉ ݏ݈݈݁ܿ ݈ܾ݁ܽ݅ݒ 10଺)ܦܥܸ Τܮ݉ )ଵ଴଴  
 
IgG Characterization 
To study the effects of the addition of resveratrol in flask cultures, a replicate experiment of the flask 
experiment as described above was used with only addition of resveratrol on day 3 at 10, 25, 50 and 
100 µM concentrations. A read-out of VCD and viability was performed every 48 hours and the IgG 
concentration was measured on day 10. This was done in 4 independent replicates. 
Cell culture was centrifuged and the supernatant was filtered and purified with an ÄKTATM pure (GE 
Healthcare) with the use of a 1x5 ml HiTrapTM MabSelect SureTM protein A column (GE Healthcare) and 
then stored at -80oC until further analysis by size exclusion chromatography (HPLC SEC), cation 
exchange chromatography (HPLC CEX) and liquid chromatography tandem mass spectrometry (HPLC-
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Experimental results were expressed as mean ± 1 SD for those results generated from at least 3 
independent cultures. Results were evaluated for statistical significance through one-way ANOVA 
tests, p-values were considered significant below 0.05. 
 
Results 
1mL Multiwell Study with Cell Cycle Analysis 
The time course study undertaken in 24-well plates (Figure 2) showed that resveratrol inhibited CHO 
cell growth in a concentration-dependant manner. While 10 µM treatment did not cause marked 
changes in the growth behaviour of the CHO cell culture. There was a minor increase in cell diameter 
around 16 hours after inoculation but the culture recovered by 24 hours and subsequently behaved 
like the untreated control. The cell cycle analysis showed no observable difference in the ratio of 
G1/G0, S and G2/M between the 10mM resveratrol treatment and the untreated control. 
Treatment of the CHO cell culture with 25 µM resveratrol had an observable effect on growth (Figure 
2). The VCD was reduced for the first 48 hours after inoculation before the culture started to grow at 
a rate similar to the untreated control. The viability dropped below 95% 24 and 32 hours after 
inoculation which coincided with an increase in cell diameter, before both viability and cell diameter 
returned to levels in the untreated control. The cell cycle analysis (Figure 3) showed an observable 
difference between the 25 mM resveratrol treatment group and the untreated control. 24 hours after 
inoculation there was a decline in the proportion of S phase cells and a rise in cells in the G1/G0 and 
G2/M phase which was temporary but the culture took 48 hours to stabilise to the proportions seen 
in the untreated control. 
50mM resveratrol treatment had a marked effect on CHO cells (Figure 2). The VCD was checked for 
the first 48 hours after inoculation before starting to recover. The cell viability declined after 
inoculation dropping below 90% at 48 hours. The cells also had a steady increase in diameter for the 
first 48 hours before starting to return to the levels in the untreated control. The cell cycle analysis 
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(Figure 3) differed markedly from the untreated control with a dramatic decline in G1/G0 phase cells 
and equally dramatic rise in S phase cells 32 hours after inoculation. 
The 1 mL multiwell study demonstrated resveratrols capacity to impede CHO cell growth in a 
concentration dependant manner. The effect was observed to be temporary with cell growth 
returning around 48 hours after the treatment starts. Addition of the resveratrol at the same time as 
inoculation may have exacerbated the check on growth as the cells are adjusting to the change in 
environment during the inoculation process. The following experiment was designed to determine 
whether the time of resveratrol addition effected its ability to check cell growth and determine what 
effect resveratrol had on IgG synthesis and quality. 
 
33 mL Erlenmeyer Flask CHO Cell Growth and IgG Expression 
The growth in a 33 mL Erlenmeyer flask enables CHO cell growth to be studied over a longer time span 
than the 1 mL multiwell plate. It also enables IgG synthesis to be studied and the cell specific 
productivity to be calculated.  
CHO cells were grown in 33 ml volumes Erlenmeyer shake flasks for a period of 10 days and the IgG 
concentration measured. Resveratrol was added to the cultures on days 0, 3 and 6 after inoculation 
and VCD, viability and IgG concentration measure (Figure 4).  
TｴW ;SSｷデｷﾗﾐ ﾗa ヲヵ ´M ヴWゲ┗Wヴ;デヴﾗﾉ ﾗﾐ S;┞ ヰ delayed the rise in VCD by approximately 1 to 2 days as 
observed in the 24-well plate experiment. The decline in viable cells at the end of the culture was also 
delayed presumably as the nutrients were not spent as they would have been in the untreated control. 
The expression of IgG was also delayed but reached similar levels to the untreated control while the 
specific protein productivity (qp) was increased from 2.76 +/- 0.16 to 3.24 +/- ヰくヱΑく ASSｷデｷﾗﾐ ﾗa ヲヵ ´M 
resveratrol on day 3 and 6 had little impact on CHO cell growth with marginal impact on VCD and 
viability. There was a marginal increase in IgG concentration associated with the day 6 addition of 25 
´M ヴWゲ┗Wヴ;デヴﾗﾉ from 177+/-2 to 203+/-4 µg/ml and specific protein productivity from 2.76 to 3.38 
pg/cell⋅day (Figure 5). 
TｴW ;SSｷデｷﾗﾐ ﾗa ヵヰ ´M ヴWゲ┗Wヴ;デヴﾗﾉ ｷﾐ ンン ﾏﾉ ┗ﾗﾉ┌ﾏWゲ Erlenmeyer shake flasks on day 0 delayed the rise 
in VCD (as observed in the 1 mL experiment), a temporary drop in viability and a delay in IgG synthesis 
which never reached the concentration observed in the untreated control. The effect on cell growth 
and IｪG ゲ┞ﾐデｴWゲｷゲ ﾗa ヵヰ ´M ヴWゲ┗Wヴ;デヴﾗﾉ ;SSｷデｷﾗﾐ ┘;ゲ SWヮWﾐS;ﾐデ ﾗﾐ デｴW デｷﾏW ﾗa ;SSｷデｷﾗﾐ ふFｷｪ┌ヴW ヴぶく TｴW 
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calculated qp increased by 65% (4.55 pg/cell⋅day) when the resveratrol was added on Day 0. Addition 
of 50 mM resveratrol 3 days after inoculation caused a temporary pause (around 24 hour) in cell 
growth, a bearly detectable dip in viability and delay in IgG synthesis. The VCD never reached the 
concentration observed in the untreated control but the IgG synthesis was very similar (by day 10). 
The calculated qp, however was 51% greater (4.17 pg/cell⋅day). Treatment with 50 mM resveratrol at 
day 6 did not cause changes in the viability curve. It was associated with a increased synthesis of IgG 
over the 10 day experiment. The increase of the calculated qp was, however, not significant probably 
due to the late addition of the resveratrol. The qp values for each treatment are shown in Figure 5. 
 
IgG Characterization (HPLC CEX, HPLC SEC and HPLC-MS/MS) 
The 33 mL Erlenmeyer flask containing CHO cell cultures were treated at day 3 with 10, 25 and 50 ´M 
resveratrol and the quality of the IgG assessed by HPLC SEC, HPLC CEX and HPLC-MS/MS analysis. The 
growth curves were similar to the ones previously described. 
HPLC SEC showed that the IgG purified using protein A chromatography had at least 95% in the 
monomeric form. No peaks were identified prior to the monomeric peak at 13.67 min, suggesting  that 
aggregate formation was not a problem for this process. Aggregates in the reactor that do not bind to 
protein A resin were not measured in this experiment. The fraction of lower molecular weight 
fragments was also uneffected by the presence of resveratrol. Peaks at 16.24 and 17.34 min of the 
IgG were consistent across all resveratrol treatments, showing no difference with respect to the 
control (Figure A).   
HPLC CEX showed that the main isoform peak accounted for over 54% of the molecules, with acidic 
species representing 28% and basic species 18%. There were no significant changes in any of the peaks 
or in the total acidic or basic species relative quantities across the different resveratrol treatments 
(Figure 6 and 7).  
Finally, the use of HPLC-MS/MS showed an absence of IgG modification patterns that could be linked 
to resveratrol addition (see Supplmentary Information). The average sequence coverage for the 20 
analysed samples was 97% for the light chain (LC) and 77% for the heavy chain (HC). Identification 
score for both HC and LC was 323.31, which is the highest score that MaxQuant is able to provide. 
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These values were consistent across treatments. Quantitative comparison of dependent peptide 
searches and targeted searches for IgG modifications provided no significant results.  
 
Discussion 
The results from this study suggest that resveratrol acts on CHO cells by slowing the cell growth and 
increasing the cell specific protein productivity without changing the characteristics of the IgG 
produced. Previous studies failed to show this because they only used one concentration of 
ヴWゲ┗Wヴ;デヴﾗﾉ ふヱヰ´Mぶ.16 Treatment with 10 µM resveratrol does not have a marked effect on CHO cell 
cultures and does not differ much from the control in terms of viability, VCD and protein production.17 
 
Cytostaticity and toxicity mechanisms 
Resveratrol ふヲヵ ;ﾐS ヵヰ ´Mぶ had an effect on CHO cell flask cultures which was dependant on the time 
of addition of the resveratrol. Addition of resveratrol to the flask cultures at the same time as 
inoculation was effective slowing the cells adaption to the new media and subsequent cell growth. 
The stationary stage lengthened as resveratrol concentration increased. The build-up of CHO cells in 
the S-ヮｴ;ゲW ;デ ヱヶ ｴﾗ┌ヴゲ ヮﾗゲデ ｷﾐﾗI┌ﾉ;デｷﾗﾐ aﾗヴ ヲヵ ´M ヴWゲ┗Wヴ;デヴﾗﾉ ;SSｷデｷﾗﾐ ;ﾐS ;デ ンヲ ｴﾗ┌ヴゲ post 
inoculation for 50 mM resveratrol addition followed by rapid decrease in S-phase cells is indicative of 
resveratrol slowing the DNA synthesis which is overcome by the cell causing imbalance in the 
proportion of cells in the different phases which then stabilises. Resveratrol is known to interfere with 
DNA duplication, repair and segregation 20,21 accumulating cells in the S phase through direct and 
indirect mechanisms late in the culture.22-25 This has been observed previously; DNA damage occurred 
at high concentrations with the subsequent possibility of apoptotic events,20,26 although that was not 
always the case.27 One of the mechanisms by which resveratrol could be causing toxicity in CHO cell 
dividing cultures may be linked to its interaction with topoisomerases during the S phase.20,28,29 
 
Cell growth and specific productivity 
The addition of resveratrol to flask cultures at the time of inoculation slowed cell growth by 
lengthening the stationary phase and caused underproduction of the final titre, although qP was 
improved. The treatment of the cell culture at a late stage of the exponential phase caused an increase 
in the final titre due to the reduced capacity of resveratrol to cause toxic effects in a stationary culture 
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while improving the specific protein production. Characterization of the IgG after treatment showed 
no main changes, indicating that this mechanism of treatment does not cause any undesired changes 
to the product of interest. 
The inverse relationship between cell growth and specific productivity is not unique to resveratrol; 
other systems with similar effects on CHO cells have been used to accomplish this biphasic effect in 
order to improve the recombinant protein production. Two well studied ways to achieve this goal are, 
shifting to lower temperatures and adding sodium butyrate (NaBu). The mechanism of action of low 
temperature is not clearly understood but it is linked to cell cycle arrest in the G1 phase.30 Low 
temperatures have the capacity to slow down growth, increase cell size and prolong viability; all these 
factors cause an increase in the qp 31 as well as final titre to up to 5 times.32,33 This improvement is 
subjected to specific conditions and changes in media composition, recombinant product or producer 
cell line could result in no significant improvement of recombinant production.34,35 NaBu is a well-
studied chemical that is able to improve recombinant IgG production. This is done by sustaining high 
nutrient consumption and increasing the biosynthetic activity especially during the stationary phase, 
which translates in an increase of qp.36 Another mechanism of action was described where NaBu 
helped proper assembly of IgGs.37 NaBu can result in a 2-fold increase of the qp and the final 
concentration, and was attributed to improving gene accessibility. The benefits of NaBu were variable 
between clone lines.3 Further studies successfully combined low temperatures and addition of NaBu 
to further improve yields of IgGs.38 
 
IgG characterization 
Characterization of the IgG in our study showed that resveratrol caused no changes in aggregation, 
fragmentation or charged variants. Chemical additives with the property to shift the compositions of 
antibodies charge variants are not unknown. The antioxidant flavanol, EGCG was found to cause 
reduction of acidic species 39 and in some cases the chemical additives such as  NaBu, causes non 
desired changes.37 The HPLC-MS/MS analyses did not identify any modifications that would shift of 
charge variants as seen by cation exchange chromatograms.  
 
Applications 
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The capacity of resveratrol to enhance recombinant production is not unique. Some other small 
molecules have been proven capable of enhancing protein production while slowing down growth; 
examples include betaine, 4-phenylbutyric acid, valproic acid and valeric acid.2,5,40-43 Betaine is a 
chemical used in combination with high osmotic conditions in order to enhance productivity in difficult 
to express proteins although its effectiveness varies between cell and clone lines.2,44,45 Regarding 4-
phenylbutyric acid, it is a chemical chaperone used in cases where it is difficult to express proteins.43 
Although the other chemicals have been proven to be successful in improving specific production, 
little is known about their mechanism of action. Each chemical may prove to be advantageous, 
depending on the cell growth media, the cell line, recombinant protein or specific difficulty 
encountered. Because of this, it is important to widen the number of additives that can be used to 
engineer the production process.  
Resveratrol is a successful candidate in improving cell specific productivity which effects the  charge 
species of the recombinant protein produced. Although more studies are required in order to further 
understand the mechanism of action of resveratrol, this flavonoid seems to have a unique complex 
effect in improving recombinant IgG production, which seems to differ from the other media additives 
studied so far. Resveratrols free radical scavenging properties make it an attractive option where 
chemical stability of the recombinant protein is an issue.  
 
Conclusions 
Resveratrol is toxic to CHO cells at 100 mM concentration,17 but at sub-toxic concentrations caused 
cell growth arrest in a concentration-dependent-manner while increasing the cell specific productivity 
of the recombinant monoclonal antibody. There was no detectable impact of 25 mM or 50 mM 
resveratrol on post translational modification. Similarly there was no chemical reaction with the 
therapeutic protein or evidence of increased chemical modification of the IgG in the presence of sub-
toxic concentrations of resveratrol. 
The use of resveratrol during the production of a stable monoclonal antibody (as conducted in this 
paper) gives a significant increase in qp due to slight increase in IgG concentration and a reduction in 
cell density. While this observation is interesting, where resveratrol could be of real benefit is in the 
production of proteins which are vulnerable to chemical modification. Resveratrol has known 
capability to protect against free radicals at 25 and 50 mM concentrations46 and has the potential to 
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be used with therapeutic proteins. Based on this study, we suggest that resveratrol should be 
considered as an additive to cell culture media. 25 mM resveratrol had minimal impact of CHO cell 
growth and could be used in a cell culture reactor. If 50 mM resveratrol is used, its negative effect on 
cell viability is reduced if it is added to actively growing cells and addition of resveratrol should be 
avoided in the initial media. 
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Figure 1. The chemical structure of resveratrol 
Figure 2. Effect of resveratrol (Resv) on viable cell density (A), viability (B) and cell diameter (C)  at 0 
(red triangle) 10 µM (yellow diamond), 25 µM (green square) and 50 µM (blue circle) treatments for 
CHO cells grown in 24-well plates. Each data point represents the average from a triplicate, and the 
error bars correspond to ±SD. These experiments were repeated independently. 
Figure 3. Profile of resveratrol (Resv) treatment effect at 0, 10, 25 and 50 µM over the relative 
amount of cells in different phases of the cell cycle G1/G0 (red triangle), S (green squared) and G2/M 
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(blue circle) for a period of 3 days for CHO cells grown in 24-well plates. Each data point represents 
the average from a triplicate, and the error bars correspond to ±SD. These experiments were 
repeated independently. 
Figure 4. Profiles comparison of viable cell densities (VCD) (A), viability (B) and IgG concentration (C) 
for 33 ml batch cultures run 10 days in a shaking humidified incubator and treated with resveratrol 
(Resv) concentrations of 25 µM (Left) and 50 µM (Right) at days 0, 3 or 6 as specified in the legend. 
Each data point represent the average from a triplicate, and the error bars correspond to ±SD. This 
experiments was repeated independently. 
Figure 5. Relative protein production (qp) of 33 ml batch recombinant CHO cell cultures  in 125 ml 
Erlenmeyer flasks after a period of 10 days and treated with resveratrol (Resv) at 25 and 50 µM on 
days 0, 3 or 6. qp was calculated by dividing final protein production by the integral of the VCD curve. 
Each data point represent the average from a triplicate, and the error bars correspond to ±SD. This 
experiments was repeated independently. One way ANOVA statistical test was perform for the 
treatment compared to the control for p-values: (*) < 0.05, (**) < 0.01 and (***) < 0.001. 
Figure 6. Size exclusion (A) and cation exchange (B) chromatograms for purified IgG produce by 33 
ml batch cultures run 10 days in a shaking humidified incubator after a period of 10 days and treated 
with resveratrol (Resv) at 0, 10, 25, 50 and 100 µM on day 3. 
Figure 7. Relative quantification (%) of charge species for purified IgG. Data from cation exchange 
chromatography. The acidic (left), main (centre) and basic (right) species were assessed under 
resveratrol (Resv) culture additions at different concentrations. Recombinant CHO cells were grown 
for 10 days in flask cultures and treated at day 3 The IgG was then collected and purified. The error 
bars displayed here correlate to ± SD. The experiment was run 4 times independently. One way 
ANOVA statistical test was perform for the treatment compared to the control for p-values: (*)< 
0.05, (**) < 0.01 and  (***) < 0.001. 
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